Wolff Stefani
Insider CIK 1751790 · PRNB Chief Development Officer · NRIX EVP and COO · RAIN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 24,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 35,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 20,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | A Award deriv | 2023-08-09 | 2023-08-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2023-05-01 | 2023-05-02 | 342 | $9.88 | $3.4K | 6,113 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2023-04-30 | 2023-05-02 | 962 | — | $0 | 10,582 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2023-04-30 | 2023-05-02 | 962 | — | $0 | 6,455 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2023-02-14 | 2023-02-15 | 88,900 | — | $0 | 88,900 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2023-02-14 | 2023-02-15 | 24,000 | — | $0 | 24,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2023-01-30 | 2023-02-01 | 962 | — | $0 | 11,544 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2023-01-30 | 2023-02-01 | 424 | $11.78 | $5.0K | 3,940 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2023-01-30 | 2023-02-01 | 962 | — | $0 | 4,364 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-01 | 350 | $12.88 | $4.5K | 3,402 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2022-10-30 | 2022-11-01 | 962 | — | $0 | 12,506 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2022-10-30 | 2022-11-01 | 962 | — | $0 | 3,752 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2022-08-09 | 2022-08-10 | 110,375 | — | $0 | 110,375 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2022-08-01 | 2022-08-02 | 356 | $15.67 | $5.6K | 1,238 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2022-07-30 | 2022-08-02 | 962 | — | $0 | 13,468 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2022-07-30 | 2022-08-02 | 962 | — | $0 | 1,594 | SEC↗ |
| RAIN Rain Therapeutics Inc. | A Award deriv | 2022-06-01 | 2022-08-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2022-05-02 | 2022-05-03 | 330 | $11.75 | $3.9K | 632 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2022-04-30 | 2022-05-03 | 962 | — | $0 | 14,430 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2022-04-30 | 2022-05-03 | 962 | — | $0 | 962 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2022-01-19 | 2022-01-21 | 15,392 | — | $0 | 15,392 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2022-01-19 | 2022-01-21 | 34,631 | — | $0 | 34,631 | SEC↗ |
| RAIN Rain Therapeutics Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 24,000 | — | $0 | 24,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 22,017 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 16,843 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 55,042 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 55,000 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 60,000 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 30,056 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | U Tender | 2020-09-28 | 2020-09-28 | 13,592 | $100.00 | $1.36M | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | G Gift | 2020-09-18 | 2020-09-28 | 5,504 | — | $0 | 13,592 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-06-15 | 2020-06-17 | 100 | $61.37 | $6.1K | 19,096 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-06-15 | 2020-06-17 | 400 | $59.89 | $24.0K | 24,200 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-06-15 | 2020-06-17 | 5,004 | $60.81 | $304.3K | 19,196 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-03-16 | 2020-06-17 | 3,750 | $46.36 | $173.8K | 24,600 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-03-16 | 2020-06-17 | 1,754 | $45.72 | $80.2K | 28,350 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-03-16 | 2020-03-18 | 5,504 | — | $0 | 19,047 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-03-16 | 2020-03-18 | 3,750 | $46.36 | $173.8K | 35,609 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-03-16 | 2020-03-18 | 5,504 | $4.54 | $25.0K | 41,113 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-03-16 | 2020-03-18 | 1,754 | $45.72 | $80.2K | 39,359 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2020-03-05 | 2020-03-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-16 | 2020-06-17 | 4,205 | $49.29 | $207.3K | 31,404 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-16 | 2020-06-17 | 1,300 | $49.87 | $64.8K | 30,104 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2019-12-16 | 2019-12-18 | 5,505 | — | $0 | 24,551 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2019-12-16 | 2019-12-18 | 5,505 | $4.54 | $25.0K | 41,114 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-16 | 2019-12-18 | 4,205 | $49.29 | $207.3K | 36,909 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-16 | 2019-12-18 | 1,300 | $49.87 | $64.8K | 35,609 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2019-03-01 | 2019-03-08 | 60,000 | — | $0 | 60,000 | SEC↗ |